Mosaic Embryos: Should You Transfer an Embryo That Is Not Fully Normal?

Mosaic Embryos: Should You Transfer an Embryo That Is Not Fully Normal?

Getting a mosaic result on a PGT-A report is one of those moments where patients expect clarity but end up with more questions than answers. The report indicates that an embryo contains both normal and abnormal cells, sometimes expressed as a percentage or as low-level versus high-level mosaicism. It does not provide a direct recommendation, which is why the decision often feels unresolved.

Mosaicism is still an evolving area in reproductive medicine. Clinical guidance has changed over the past decade as more transfer and outcome data has accumulated, and interpretation continues to be refined rather than fixed.

How a Mosaic Embryo Forms

Very early in embryonic development, cells divide rapidly. During these divisions, errors can occur, resulting in some cells gaining or losing chromosomes while others remain normal. When both populations exist within the same blastocyst, the embryo is described as mosaic.

PGT-A testing samples cells from the trophectoderm, which later forms the placenta. It does not sample the inner cell mass, which becomes the fetus. This means the result reflects only a portion of the embryo and cannot fully define the chromosomal status of the entire structure.

Why Percentage and Chromosome Matter

Mosaic results are not uniform. The proportion of abnormal cells and the specific chromosome involved both significantly influence outcome expectations.

• Low-level mosaicism (typically under ~30 percent abnormal cells) tends to behave closer to euploid embryos in clinical outcomes.
• High-level mosaicism shows reduced implantation rates and increased miscarriage risk compared to euploid embryos.
• Some chromosome abnormalities are more compatible with ongoing development than others.
• Segmental mosaics (partial chromosome changes) follow different outcome patterns than whole-chromosome mosaics.

Interpretation should always consider both the chromosome and the level of mosaicism rather than either factor in isolation.

What Happens After Mosaic Embryo Transfer

Registry data over the past several years shows that healthy live births can and do occur after mosaic embryo transfers. This has led to their acceptance as a clinical option in selected cases rather than an experimental approach.

One proposed explanation is embryonic self-correction, where abnormal cells are confined to placental tissue or outcompeted during development. However, this process is not guaranteed, which is why mosaic embryos are not considered equivalent to euploid embryos.

Reported outcomes suggest lower live birth rates and higher miscarriage rates compared to euploid transfers, though outcomes vary significantly based on embryo characteristics and patient factors.

When the Decision Becomes Difficult

When euploid embryos are available, they are typically prioritized for transfer. The decision becomes more complex when no euploid embryos remain.

At that point, the choice may involve transferring a mosaic embryo versus undergoing another stimulation and retrieval cycle, or in some cases discontinuing treatment. This decision depends heavily on age, ovarian reserve, and prior cycle history.

For patients with reduced ovarian reserve or advanced maternal age, a low-level mosaic embryo may represent a meaningful remaining chance. For younger patients with stronger expected response to treatment, further retrieval cycles may offer higher probability of euploid embryos.

Before Proceeding With a Mosaic Transfer

Informed consent for mosaic embryo transfer should be detailed and specific. Key considerations include the chromosome involved, the level of mosaicism, and how these align with published outcome data.

Patients should also understand recommended prenatal testing pathways and monitoring strategies in case of pregnancy.

Genetic counseling with a specialist in reproductive genetics is strongly recommended, as interpretation often requires more than general fertility consultation.

Clinical Review and Next Steps

If mosaic embryos are present, interpretation should be based on the full PGT-A report alongside clinical history, rather than isolated findings.

A detailed review with a fertility specialist can help contextualize the results and determine whether transfer, further cycles, or alternative strategies are most appropriate.

MMC IVF can provide consultation to review PGT-A results and discuss treatment planning based on individual clinical circumstances.